Growth Metrics

Armata Pharmaceuticals (ARMP) Gains from Investment Securities (2016 - 2026)

Quarterly results put Gains from Investment Securities at $769.0 for Q1 2026, down 94.51% from a year ago — trailing twelve months through Mar 2026 was $769.0 (down 99.92% YoY), and the annual figure for FY2025 was $346500.0, down 71.85%.

Armata Pharmaceuticals has reported Gains from Investment Securities over the past 13 years, most recently at $769.0 for Q1 2026.

  • Gains from Investment Securities reached $769.0 in Q1 2026 per ARMP's latest filing, down from $1.6 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $8.6 million in Q4 2022 and bottomed at -$916000.0 in Q4 2024.
  • Median Gains from Investment Securities over the past 5 years was $141786.0 (2022), compared with a mean of $973396.2.
  • Peak annual rise in Gains from Investment Securities hit 37138.41% in 2024, while the deepest fall reached 1626.67% in 2024.
  • Over 5 years, Gains from Investment Securities stood at $8.6 million in 2022, then plummeted by 99.3% to $60000.0 in 2023, then tumbled by 1626.67% to -$916000.0 in 2024, then skyrocketed by 274.24% to $1.6 million in 2025, then plummeted by 99.95% to $769.0 in 2026.
  • Business Quant data shows Gains from Investment Securities for ARMP at $769.0 in Q1 2026, $1.6 million in Q3 2025, and $1.6 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 769.00
Mar 31, 2026 769.00
Sep 30, 2025 1.60 Mn
Sep 30, 2025 1.60 Mn
Jun 30, 2025 1.60 Mn
Jun 30, 2025 1.60 Mn
Mar 31, 2025 14,000.00
Mar 31, 2025 14,000.00
Dec 31, 2024 -916,000.00
Dec 31, 2024 -916,000.00
Sep 30, 2024 977,257.00
Sep 30, 2024 977,257.00
Jun 30, 2024 266,251.00
Jun 30, 2024 266,251.00
Mar 31, 2024 1.82 Mn
Mar 31, 2024 1.82 Mn
Dec 31, 2023 60,000.00
Dec 31, 2023 60,000.00
Sep 30, 2023 17,500.00
Sep 30, 2023 17,500.00
Jun 30, 2023 17,500.00
Jun 30, 2023 17,500.00
Mar 31, 2023 4,874.00
Mar 31, 2023 4,874.00
Dec 31, 2022 8.63 Mn
Dec 31, 2022 8.63 Mn
Sep 30, 2022 1.22 Mn
Sep 30, 2022 1.22 Mn
Jun 30, 2022 180,229.00
Jun 30, 2022 180,229.00
Mar 31, 2022 103,343.00
Mar 31, 2022 103,343.00
Dec 31, 2021 26.00 Mn
Dec 31, 2021 26.00 Mn
Sep 30, 2021 11,908.00
Sep 30, 2021 11,908.00
Jun 30, 2021 7,474.00
Jun 30, 2021 7,474.00
Mar 31, 2021 549,750.00
Mar 31, 2021 549,750.00
Dec 31, 2020 171,000.00
Dec 31, 2020 171,000.00
Sep 30, 2020 102,450.00
Sep 30, 2020 102,450.00
Jun 30, 2020 42,029.00
Jun 30, 2020 42,029.00
Mar 31, 2020 39,382.00
Mar 31, 2020 39,382.00
Dec 31, 2019 201,000.00
Dec 31, 2019 201,000.00
Sep 30, 2019 1.18 Mn
Sep 30, 2019 1.18 Mn
Jun 30, 2019 1.16 Mn
Jun 30, 2019 1.16 Mn
Mar 31, 2019 286,173.00
Mar 31, 2019 286,173.00
Dec 31, 2018 337,000.00
Dec 31, 2018 337,000.00
Sep 30, 2018 3,201.00
Sep 30, 2018 3,201.00
Jun 30, 2018 1,450.00
Jun 30, 2018 1,450.00
Mar 31, 2018 1,500.00
Mar 31, 2018 1,500.00
Sep 30, 2017 1.07 Mn
Sep 30, 2017 1.07 Mn
Jun 30, 2017 239,083.00
Jun 30, 2017 239,083.00
Mar 31, 2017 46,732.00
Mar 31, 2017 46,732.00
Dec 31, 2016 18,493.00
Dec 31, 2016 18,493.00
Sep 30, 2016 158,856.00
Sep 30, 2016 158,856.00
Jun 30, 2016 150,856.00
Jun 30, 2016 150,856.00